Neurosteer
Tel Aviv, Israel· Est.
Wearable AI‑enhanced EEG platform for real‑time brain health monitoring and early disease detection.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Wearable AI‑enhanced EEG platform for real‑time brain health monitoring and early disease detection.
Neurodegenerative DiseasesEpilepsyMental HealthPain ManagementNeonatal Neurology
Technology Platform
Single‑channel high‑definition EEG (hdrEEG) wearable with cloud‑based AI algorithms that decompose brain signals into network‑specific biomarkers for real‑time analysis.
Opportunities
Scalable, low‑cost brain health monitoring can unlock new diagnostic pathways, attract pharma collaborations for biomarker‑driven trials, and expand into consumer wellness markets.
Risk Factors
Demonstrating clinical utility across indications, securing reimbursement, and competing with established EEG and neuroimaging solutions pose significant challenges.
Competitive Landscape
Competitors include Muse, Emotiv, BrainScope, and traditional EEG manufacturers; Neurosteer differentiates through FDA‑cleared medical‑grade hardware and AI‑driven single‑channel signal decomposition.